ZEB2 and myeloproliferative disorder: It was presented in a hematologic study that ZEB2 knockout in the bone marrow could lead to phenotypes resembling myeloproliferative disorders, which may be mediated by its downstream JAK-STAT and ERK pathways, according to KEGG analysis.